缺铁性贫血患者缺铁与左室重构的相关性研究

陈炎, 夏海丹, 李亚, 等. 缺铁性贫血患者缺铁与左室重构的相关性研究[J]. 临床心血管病杂志, 2019, 35(5): 458-462. doi: 10.13201/j.issn.1001-1439.2019.05.016
引用本文: 陈炎, 夏海丹, 李亚, 等. 缺铁性贫血患者缺铁与左室重构的相关性研究[J]. 临床心血管病杂志, 2019, 35(5): 458-462. doi: 10.13201/j.issn.1001-1439.2019.05.016
CHEN Yan, XIA Haidan, LI Ya, et al. Correlation of iron deficiency and left ventricular remodeling in patients with iron dediciency anemia[J]. J Clin Cardiol, 2019, 35(5): 458-462. doi: 10.13201/j.issn.1001-1439.2019.05.016
Citation: CHEN Yan, XIA Haidan, LI Ya, et al. Correlation of iron deficiency and left ventricular remodeling in patients with iron dediciency anemia[J]. J Clin Cardiol, 2019, 35(5): 458-462. doi: 10.13201/j.issn.1001-1439.2019.05.016

缺铁性贫血患者缺铁与左室重构的相关性研究

  • 基金项目:

    国家自然科学基金(No:81670409)

详细信息
    通讯作者: 万静,E-mail:wanjing_zn@163.com
  • 中图分类号: R542.2

Correlation of iron deficiency and left ventricular remodeling in patients with iron dediciency anemia

More Information
  • 目的:探讨缺铁性贫血患者铁指标与心脏彩超左室质量指数(LVMI)的相关性,验证缺铁引起的铁指标异常作为左心室重构危险因素的可行性。方法:纳入2013-2018年武汉大学中南医院收治的83例缺铁性贫血患者。收集患者临床血常规、生化检查、铁指标、心脏彩超检查等结果。任何其他并发疾病均列为排除标准。对其中66例患者计算LVMI,根据LVMI (男性>115 g/m2,女性>95 g/m2)结果分为正常组和异常组,对两组患者的所有研究指标进行两两比较。在83例患者中,采用相关性分析分别评估血红蛋白、总铁结合力(TIBC)与其他研究指标的相关性。以log变换后的LVMI作为应变量,采用线性回归分析log变换LVMI与其他研究指标的线性相关性。采用logistic回归分析贫血及TIBC水平与心室重构的关系。结果:在LVMI异常组中可以观察到更高的TIBC水平。线性相关分析显示,HGB与RDW、血清铁、TS、LVM明显相关,TIBC与年龄、MCV、铁蛋白、TS、LVM、SV、白蛋白明显相关,TIBC与HGB无相关性。多重线性回归分析显示,log变换LVMI与年龄、TIBC及HGB有明显相关性。logistic回归分析显示,贫血程度及TIBC与左心室重构发生风险相关,在调整贫血影响后,TIBC仍与左心室重构相关。结论:在缺铁性贫血患者中,TIBC与LVMI密切相关,升高的TIBC可增加这一患病群体发生左心室重构的风险。
  • 加载中
  • [1]

    Mclean E, Cogswell M, Egli I, et al.Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005[J].Public Health Nutr, 2009, 12(4):444-454.

    [2]

    Camaschella C.Iron-deficiency anemia[J].N Engl J Med, 2015, 372(19):1832-1843.

    [3]

    Hentze MW, Muckenthaler MU, Galy B, et al.Two to tango:regulation of Mammalian iron metabolism[J].Cell, 2010, 142(1):24-38.

    [4]

    Wijarnpreecha K, Kumfu S, Chattipakorn SC, et al.Cardiomyopathy associated with iron overload:how does iron enter myocytes and what are the implications for pharmacological therapy?[J].Hemoglobin, 2015, 39(1):9-17.

    [5]

    Gammella E, Recalcati S, Rybinska I, et al.Iron-induced damage in cardiomyopathy:oxidative-dependent and independent mechanisms[J].Oxid Med Cell Longev, 2015, 2015:230182.

    [6]

    Petering DH, Stemmer KL, Lyman S, et al.Iron deficiency in growing male rats:a cause of development of cardiomyopathy[J].Ann Nutr Metab, 1990, 34(4):232-243.

    [7]

    Xu W, Barrientos T, Mao L, et al.Lethal cardiomyopathy in mice lacking transferrin receptor in the heart[J].Cell Rep.2015, 13(3):533-545.

    [8]

    Lang RM, Bierig M, Devereux RB, et al.Recommendations for chamber quantification[J].Eur J Echocardiogr, 2006, 7(2):79-108.

    [9]

    Sawayama H, Iwatsuki M, Kuroda D, et al.Total iron-binding capacity is a novel prognostic marker after curative gastrectomy for gastric cancer[J].Int J Clin Oncol, 2018, 23(4):671-680.

    [10]

    Luck AN, Mason AB.Transferrin-mediated cellular iron delivery[J].Curr Top Membr, 2012, 69:3-35.

    [11]

    Gebhard C, Stahli BE, Gebhard CE, et al.Age-and gender-dependent left ventricular remodeling[J].Echocardiography, 2013, 30(10):1143-1150.

    [12]

    Kalantar-Zadeh K, Kleiner M, Dunne E, et al.Total iron-binding capacity-estimated transferrin correlates with the nutritional subjective global assessment in hemodialysis patients[J].Am J Kidney Dis, 1998, 31(2):263-272.

    [13]

    Seres DS.Surrogate nutrition markers, malnutrition, and adequacy of nutrition support[J].Nutr Clin Pract, 2005, 20(3):308-313.

    [14]

    Blayney L, Bailey-Wood R, Jacobs A, et al.The effects of iron deficiency on the respiratory function and cytochrome content of rat heart mitochondria[J].Circ Res, 1976, 39(5):744-748.

    [15]

    Rensvold JW, Ong SE, Jeevananthan A, et al.Complementary RNA and protein profiling identifies iron as a key regulator of mitochondrial biogenesis[J].Cell Rep, 2013, 3(1):237-245.

    [16]

    Arany Z, He H, Lin J, et al.Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle[J].Cell Metab, 2005, 1(4):259-271.

    [17]

    杨永曜, 李隆贵.PPARα、PPARγ及其配体对心室重构作用的研究进展[J].临床心血管病杂志, 2006, 22(1):61-63.

    [18]

    Okada Y, Tateishi K, Zhang Y.Histone demethylase JHDM2A is involved in male infertility and obesity[J].J Androl, 2010, 31(1):75-78.

    [19]

    刘德敏, 贾宏宇, 柴文静, 等.自噬与氧化应激在心血管疾病中的研究进展[J].临床心血管病杂志, 2018, 34(4):402-407.

  • 加载中
计量
  • 文章访问数:  40
  • PDF下载数:  21
  • 施引文献:  0
出版历程
收稿日期:  2018-11-10

目录